Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02289859
Other study ID # 613430
Secondary ID
Status Completed
Phase N/A
First received November 10, 2014
Last updated July 17, 2017
Start date May 2014
Est. completion date July 2016

Study information

Verified date July 2017
Source University of California, Davis
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether undermining during cutaneous surgery improves scar cosmesis compared to wound closure without undermining.


Description:

The purpose of this study is to determine whether undermining during cutaneous surgery improves scar cosmesis compared to wound closure without undermining. Our aims are to compare outcomes using a split wound model, where half the wound is undermined and the other half is not. This will be measured via the physician observer scar assessment scale, a validated scar instrument and via wound width. Our hypothesis is that wound undermining will result in cosmetically superior wound outcomes.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date July 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Able to give informed consent themselves

- Patient scheduled for cutaneous surgical procedure with predicted linear closure

- Willing to return for follow up visits

Exclusion Criteria:

- Mentally handicapped

- Incarceration

- Pregnant Women

- Wounds with predicted closure length less than 3 cm

- Wounds with diameter > 3 cm

- Wounds unable to be fully closed without undermining

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Wound Closure with Undermining
The side assigned to undermining will have undermining performed prior to wound closure in the subcutaneous plane. The amount of undermining will range from 1 cm for wounds with low tension to 2 cm for those with moderate tension. Since wound diameter will be 3 cm or less and exclude the scalp, high tension wounds are not anticipated.
Wound Closure without Undermining
One side of the wound will remain un-undermined.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of California, Davis

Outcome

Type Measure Description Time frame Safety issue
Primary Assessment of Scar on the Patient and Observer Scar Assessment Scale After surgical procedure, half of the subject's wound will be closed after undermining, while the other half is closed without undermining. After 3 months, subjects will return to clinic for evaluation of the cosmesis of both types of closure techniques. 3 months
Secondary Measurement of Scar Width The width of the scar will be measured 1 centimeter from the midline on both sides. There is no defined width that is considered satisfactory or not satisfactory. The measurements will be compared between subjects. 3 months
Secondary Assessment of Complications Noting the presence or absence of bleeding, dehiscence, infection or spitting sutures. 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02991755 - Use of 5-0 Prolene Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure N/A
Completed NCT02383186 - Dermal Suturing Only Versus Layered Cutaneous Closure N/A
Withdrawn NCT01352533 - Closure Techniques and Scar Appearance N/A
Completed NCT02547077 - Use of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure N/A
Completed NCT02550574 - Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts N/A
Completed NCT02062866 - Evaluation of Purse-String Closure Vs Second Intention N/A